ArticleTargeted oncology2022

Liquid Biopsy Assessment of Circulating Tumor Cell PD-L1 and IRF-1 Expression in Patients with Advanced Solid Tumors Receiving Immune Checkpoint Inhibitor.

Laura C Kennedy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.